Higher buprenorphine dose may boost opioid treatment success
NCT ID NCT05589181
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 30 times
Summary
This study tests whether giving a higher-than-standard dose of buprenorphine to people with opioid use disorder who test positive for fentanyl is safe and helps them start addiction treatment within a week. About 140 participants will receive either a standard or high dose in the emergency department. The goal is to see if the higher dose improves engagement in comprehensive addiction services.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rutgers University Hospital
RECRUITINGNewark, New Jersey, 07103, United States
Conditions
Explore the condition pages connected to this study.